Page 35 - Read Online

Tsai et al. Vessel Plus 2021;5:9 I http://dx.doi.org/10.20517/2574-1209.2020.73 Page 9 of 9

37. Zhang G, Li Y, Reuss JL, et al. Stable Intracerebral Transplantation of Neural Stem Cells for the Treatment of Paralysis Due to Ischemic
Stroke. Stem Cells Transl Med 2019;8:999-1007.
38. Zhang G, Cunningham M, Zhang H, et al. First Human Trial of Stem Cell Transplantation in Complex Arrays for Stroke Patients Using
the Intracerebral Microinjection Instrument. Oper Neurosurg (Hagerstown) 2020;18:503-10.
39. Wu W, Chen X, Hu C, Li J, Yu Z, Cai W. Transplantation of neural stem cells expressing hypoxia-inducible factor-1alpha (HIF-1alpha)
improves behavioral recovery in a rat stroke model. J Clin Neurosci 2010;17:92-5.
40 Stroemer P, Patel S, Hope A, Oliveira C, Pollock K, Sinden J. The neural stem cell line CTX0E03 promotes behavioral recovery and
endogenous neurogenesis after experimental stroke in a dose-dependent fashion. Neurorehabil Neural Repair 2009;23:895-909.
41. Strecker JK, Olk J, Hoppen M, et al. Combining Growth Factor and Bone Marrow Cell Therapy Induces Bleeding and Alters Immune
Response After Stroke in Mice. Stroke 2016;47:852-62.
42. England TJ, Sprigg N, Alasheev AM, et al. Granulocyte-Colony Stimulating Factor (G-CSF) for stroke: an individual patient data meta-
analysis. Sci Rep 2016;6:36567.
43. Wagner DC, Pösel C, Schulz I, et al. Allometric dose retranslation unveiled substantial immunological side effects of granulocyte colony-
stimulating factor after stroke. Stroke 2014;45:623-6.
44. Singh M, Pandey PK, Bhasin A, Padma MV, Mohanty S. Application of Stem Cells in Stroke: A Multifactorial Approach. Front Neurosci
2020;14:473.
45. Ding DC, Shyu WC, Lin SZ. Mesenchymal stem cells. Cell Transplant 2011;20:5-14.
46. Scruggs BA, Semon JA, Zhang X, et al. Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms
in the experimental autoimmune encephalomyelitis mouse model. Stem Cells Transl Med 2013;2:797-807.
47. Gutiérrez-Fernández M, Rodríguez-Frutos B, Otero-Ortega L, Ramos-Cejudo J, Fuentes B, Díez-Tejedor E. Adipose tissue-derived stem
cells in stroke treatment: from bench to bedside. Discov Med 2013;16:37-43.
48. Hess DC, Sila CA, Furlan AJ, Wechsler LR, Switzer JA, Mays RW. A double-blind placebo-controlled clinical evaluation of MultiStem
for the treatment of ischemic stroke. Int J Stroke 2014;9:381-6.
49. Vahidy FS, Rahbar MH, Zhu H, Rowan PJ, Bambhroliya AB, Savitz SI. Systematic Review and Meta-Analysis of Bone Marrow-Derived
Mononuclear Cells in Animal Models of Ischemic Stroke. Stroke 2016;47:1632-9.
50. Chan TM, Harn HJ, Lin HP, et al. The use of ADSCs as a treatment for chronic stroke. Cell Transplant 2014;23:541-7.
51. Prasad K, Sharma A, Garg A, et al; InveST Study Group. Intravenous autologous bone marrow mononuclear stem cell therapy for
ischemic stroke: a multicentric, randomized trial. Stroke 2014;45:3618-24.
52. Watanabe M, Yavagal DR. Intra-arterial delivery of mesenchymal stem cells. Brain Circ 2016;2:114-7.
53. Sung PH, Lin HS, Lin WC, et al. Intra-carotid arterial transfusion of autologous circulatory derived CD34 cells for old ischemic stroke
+
patients - a phase I clinical trial to evaluate safety and tolerability. Am J Transl Res 2018;10:2975-89.
54. Wang Y, Huang J, Li Y, Yang GY. Roles of chemokine CXCL12 and its receptors in ischemic stroke. Curr Drug Targets 2012;13:166-72.
55. Sarugaser R, Hanoun L, Keating A, Stanford WL, Davies JE. Human mesenchymal stem cells self-renew and differentiate according to a
deterministic hierarchy. PLoS One 2009;4:e6498.
56. Hernández R, Jiménez-Luna C, Perales-Adán J, Perazzoli G, Melguizo C, Prados J. Differentiation of Human Mesenchymal Stem Cells
towards Neuronal Lineage: Clinical Trials in Nervous System Disorders. Biomol Ther (Seoul) 2020;28:34-44.